会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Rapid quantitative analysis of proteins or protein function in complex mixtures
    • 蛋白质或蛋白质功能在复杂混合物中的快速定量分析
    • US06852544B2
    • 2005-02-08
    • US09839884
    • 2001-04-20
    • Rudolf Hans AebersoldMichael H. GelbSteven P. GygiC. Ronald ScottFrantisek TurecekScott A. GerberBeate Rist
    • Rudolf Hans AebersoldMichael H. GelbSteven P. GygiC. Ronald ScottFrantisek TurecekScott A. GerberBeate Rist
    • G01N27/62C12Q1/25C12Q1/34C12Q1/48G01N30/00G01N30/06G01N30/60G01N30/72G01N30/88G01N33/53G01N33/566G01N33/58G01N33/68
    • G01N33/6848C12Q1/25G01N33/58G01N33/6803G01N33/6842Y10S530/812Y10T436/182Y10T436/24Y10T436/25Y10T436/25125Y10T436/25375
    • Analytical reagents and mass spectrometry-based methods using these reagents for the rapid, and quantitative analysis of proteins or protein function in mixtures of proteins. The methods employ affinity labeled protein reactive reagents having three portions: an affinity label (A) covalently linked to a protein reactive group (PRG) through a linker group (L). The linker may be differentially isotopically labeled, e.g., by substitution of one or more atoms in the linker with a stable isotope thereof. These reagents allow for the selective isolation of peptide fragments or the products of reaction with a given protein (e.g., products of enzymatic reaction) from complex mixtures. The isolated peptide fragments or reaction products are characteristic of the presence of a protein or the presence of a protein function in those mixtures. Isolated peptides or reaction products are characterized by mass spectrometric (MS) techniques. The reagents also provide for differential isotopic labeling of the isolated peptides or reaction products which facilitates quantitative determination by mass spectrometry of the relative amounts of proteins in different samples. The methods of this invention can be used for qualitative and quantitative analysis of global protein expression profiles in cells and tissues, to screen for and identify proteins whose expression level in cells, tissue or biological fluids is affected by a stimulus or by a change in condition or state of the cell, tissue or organism from which the sample originated.
    • 使用这些试剂的分析试剂和基于质谱的方法用于蛋白质混合物中蛋白质或蛋白质功能的快速和定量分析。 该方法采用具有三个部分的亲和标记的蛋白质反应试剂:通过连接基团(L)与蛋白质反应基团(PRG)共价连接的亲和标记(A)。 连接体可以是差异同位素标记的,例如用连接体中的一个或多个原子用其稳定同位素取代。 这些试剂允许从复杂混合物中选择性分离肽片段或与给定蛋白质(例如,酶反应产物)反应的产物。 分离的肽片段或反应产物是这些混合物中存在蛋白质或存在蛋白质功能的特征。 分离的肽或反应产物的特征在于质谱(MS)技术。 试剂还提供分离的肽或反应产物的差异同位素标记,其有助于通过质谱法定量测定不同样品中蛋白质的相对量。 本发明的方法可用于细胞和组织中全球蛋白质表达谱的定性和定量分析,筛选和鉴定细胞,组织或生物流体中的表达水平受刺激或病情变化影响的蛋白质 或来自样品的细胞,组织或生物体的状态。
    • 2. 发明授权
    • Rapid quantitative analysis of proteins or protein function in complex mixtures
    • 蛋白质或蛋白质功能在复杂混合物中的快速定量分析
    • US06670194B1
    • 2003-12-30
    • US09383062
    • 1999-08-25
    • Rudolf Hans AebersoldMichael H. GelbSteven P. GygiC. Ronald ScottFrantisek TurecekScott A. GerberBeate Rist
    • Rudolf Hans AebersoldMichael H. GelbSteven P. GygiC. Ronald ScottFrantisek TurecekScott A. GerberBeate Rist
    • C07C33116
    • G01N33/6848C12Q1/25G01N33/58G01N33/6803G01N33/6842Y10S530/812Y10T436/182Y10T436/24Y10T436/25Y10T436/25125Y10T436/25375
    • Analytical reagents and mass spectrometry-based methods using these reagents for the rapid, and quantitative analysis of proteins or protein function in mixtures of proteins. The methods employ affinity labeled protein reactive reagents having three portions: an affinity label (A) covalently linked to a protein reactive group (PRG) through a linker group (L). The linker may be differentially isotopically labeled, e.g., by substitution of one or more atoms in the linker with a stable isotope thereof. These reagents allow for the selective isolation of peptide fragments or the products of reaction with a given protein (e.g., products of enzymatic reaction) from complex mixtures. The isolated peptide fragments or reaction products are characteristic of the presence of a protein or the presence of a protein function in those mixtures. Isolated peptides or reaction products are characterized by mass spectrometric (MS) techniques. The reagents also provide for differential isotopic labeling of the isolated peptides or reaction products which facilitates quantitative determination by mass spectrometry of the relative amounts of proteins in different samples. The methods of this invention can be used for qualitative and quantitative analysis of global protein expression profiles in cells and tissues, to screen for and identify proteins whose expression level in cells, tissue or biological fluids is affected by a stimulus or by a change in condition or cell state of the cell, tissue or organism from which the sample originated.
    • 使用这些试剂的分析试剂和基于质谱的方法用于蛋白质混合物中蛋白质或蛋白质功能的快速和定量分析。 该方法采用具有三个部分的亲和标记的蛋白质反应试剂:通过连接基团(L)与蛋白质反应基团(PRG)共价连接的亲和标记(A)。 连接体可以是差异同位素标记的,例如用连接体中的一个或多个原子用其稳定同位素取代。 这些试剂允许从复杂混合物中选择性分离肽片段或与给定蛋白质(例如,酶反应产物)反应的产物。 分离的肽片段或反应产物是这些混合物中存在蛋白质或存在蛋白质功能的特征。 分离的肽或反应产物的特征在于质谱(MS)技术。 试剂还提供分离的肽或反应产物的差异同位素标记,其有助于通过质谱法定量测定不同样品中蛋白质的相对量。 本发明的方法可用于细胞和组织中全球蛋白质表达谱的定性和定量分析,筛选和鉴定细胞,组织或生物流体中的表达水平受刺激或病情变化影响的蛋白质 或来自样品的细胞,组织或生物体的细胞状态。
    • 4. 发明申请
    • TARGETING MTOR SUBSTRATES IN TREATING PROLIFERATIVE DISEASES
    • 靶向治疗增生性疾病的MTOR基质
    • US20130252950A1
    • 2013-09-26
    • US13825723
    • 2011-09-23
    • John BlenisSteven P. GygiYonghao Yu
    • John BlenisSteven P. GygiYonghao Yu
    • C12Q1/48G01N33/68
    • C12Q1/485G01N33/5011G01N33/68G01N33/74G01N2333/4703
    • Provided are over 300 mTOR kinase targets identified by a comprehensive phosphoproteomics assay. Methods of targeting mTOR kinase targets, methods to determine the level of mTOR activity by measuring the level of phosphorylation of an mTOR targeted phosphorylation site, methods for distinguishing different classes of mTOR activity in a cell based on phosphoproteomic analysis of mTOR-targeted proteins are also provided. Also provided is the classification of a hyperproliferative disease based on phosphoproteomic analysis of mTOR-targeted proteins, as well as the personalization of therapeutic methods for the treatment of hyperproliferative disease based on phosphoproteomics. Also provided are therapeutic methods including administering to a subject an mTOR inhibitor, an mTOR inhibitor and an additional kinase inhibitor, or a dual inhibitor of mTOR and an additional kinase based on the phosphorylation levels of mTOR targets determined in the subject. Some aspects of this invention relate to the discovery that GrblO is an mTOR-targeted tumor suppressor gene.
    • 提供了通过综合磷酸化蛋白质测定法鉴定的超过300个mTOR激酶靶标。 靶向mTOR激酶靶标的方法,通过测量mTOR靶向磷酸化位点的磷酸化水平来测定mTOR活性水平的方法,基于mTOR靶向蛋白质的磷酸化蛋白质分析来区分细胞中不同种类的mTOR活性的方法也是 提供。 还提供了基于mTOR靶向蛋白质的磷酸化蛋白质组学分析的过度增殖性疾病的分类,以及基于磷酸化蛋白质处理过度增殖性疾病的治疗方法的个性化。 还提供了治疗方法,包括向受试者施用mTOR抑制剂,mTOR抑制剂和另外的激酶抑制剂,或mTOR的双重抑制剂和基于受试者确定的mTOR靶标的磷酸化水平的另外的激酶。 本发明的一些方面涉及GrblO是mTOR靶向的肿瘤抑制基因的发现。
    • 5. 发明授权
    • Capture and release based isotope tagged peptides and methods for using the same
    • 捕获和释放基于同位素标记的肽及其使用方法
    • US07332613B2
    • 2008-02-19
    • US10863589
    • 2004-06-07
    • Steven P. GygiScott Anthony GerberCarlos Augusto Gartner
    • Steven P. GygiScott Anthony GerberCarlos Augusto Gartner
    • C07D235/02
    • G01N33/6848G01N33/6842G01N2458/15Y10T436/24
    • The invention provides non-affinity based isotope tagged peptides, chemistries for making these peptides, and methods for using these peptides. In one aspect, tags comprise a reactive site (RS) for reacting with a molecule on a protein to form a stable association with the peptide (e.g., a covalent bond) and an anchoring site (AS) group for reversibly or removably anchoring the tag to a solid phase such as a resin support. Anchoring may be direct or indirect (e.g., through a linker molecule). Preferably, the anchoring site comprises a biotin compound. Preferably, the tag comprises a mass-altering label, such as a stable isotope, such that association of the tag with the peptide can be monitored by mass spectrometry. The reagents can be used for rapid and quantitative analysis of proteins or protein function in mixtures of proteins.
    • 本发明提供了基于非亲和力的同位素标记的肽,用于制备这些肽的化学物质和使用这些肽的方法。 一方面,标签包含用于与蛋白质上的分子反应以与肽(例如共价键)和锚定位点(AS)组稳定结合的反应位点(RS),用于可逆地或可拆卸地锚定标签 固相如树脂载体。 锚定可以是直接的或间接的(例如通过连接体分子)。 优选地,锚定位点包含生物素化合物。 优选地,标签包含质量变化标签,例如稳定同位素,使得可以通过质谱法监测标签与肽的缔合。 这些试剂可用于蛋白质混合物中蛋白质或蛋白质功能的快速和定量分析。
    • 6. 发明申请
    • Detection and quantification of modified proteins
    • 修饰蛋白的检测和定量
    • US20120149883A1
    • 2012-06-14
    • US13284255
    • 2011-10-28
    • Steven P. GygiJunmin Peng
    • Steven P. GygiJunmin Peng
    • C07K17/00C07K16/00
    • G01N33/6848C07K1/22C07K7/08C12Q1/37G01N33/6803G01N33/6842G01N33/6896G01N2440/36G01N2560/00Y10T436/24
    • The invention provides a method detecting and quantifying proteins by mass spectrophotometric analysis using peptide internal standards and provides a highly sensitive way of detecting protein modifications. In one aspect, the invention provides a method for determining a site of ubiquitination in a polypeptide and for evaluating ubiquitination targets in a population of polypeptides. In this way, a proteome ubiquitination map can be obtained which comprises information relating to the ubiquitination states of a plurality of cellular polypeptides. Maps can be obtained for a variety of different types of cells and cell states. For example, ubiquitination targets in normal and diseased cells can be evaluated. Preferably, the map is stored as data files in a database. Individual ubiquitinated polypeptides identified can be used to generate molecular probes diagnostic of a cell state and/or can serve as targets for agents that modulate one or more cellular processes.
    • 本发明提供了通过使用肽内标的质谱分析法检测和定量蛋白质的方法,并提供了检测蛋白质修饰的高度灵敏的方法。 一方面,本发明提供了一种确定多肽泛素化位点的方法,并用于评价多肽群体中的泛素化靶标。 以这种方式,可以获得包含与多个细胞多肽的泛素化状态有关的信息的蛋白质组泛素化图。 可以获得各种不同类型的细胞和细胞状态的图。 例如,可以评估正常和患病细胞中的泛素化靶标。 优选地,地图作为数据文件存储在数据库中。 鉴定的单个泛素化多肽可用于产生诊断细胞状态的分子探针和/或可用作调节一种或多种细胞过程的试剂的靶标。
    • 8. 发明授权
    • Detection and quantification of modified proteins
    • 修饰蛋白的检测和定量
    • US08669116B2
    • 2014-03-11
    • US10506877
    • 2003-03-11
    • Steven P. GygiJunmin Peng
    • Steven P. GygiJunmin Peng
    • C12Q1/37C07K1/22G01N33/68
    • G01N33/6848C07K1/22C07K7/08C12Q1/37G01N33/6803G01N33/6842G01N33/6896G01N2440/36G01N2560/00Y10T436/24
    • The invention provides a method detecting and quantifying proteins by mass spectrophotometric analysis using peptide internal standards and provides a highly sensitive way of detecting protein modifications. In one aspect, the invention provides a method for determining a site of ubiquitination in a polypeptide and for evaluating ubiquitination targets in a population of polypeptides. In this way, a proteome ubiquitination map can be obtained which comprises information relating to the ubiquitination states of a plurality of cellular polypeptides. Maps can be obtained for a variety of different types of cells and cell states. For example, ubiquitination targets in normal and diseased cells can be evaluated. Preferably, the map is stored as data files in a database. Individual ubiquitinated polypeptides identified can be used to generate molecular probes diagnostic of a cell state and/or can serve as targets for agents that modulate one or more cellular processes.
    • 本发明提供了通过使用肽内标的质谱分析法检测和定量蛋白质的方法,并提供了检测蛋白质修饰的高度灵敏的方法。 一方面,本发明提供了一种确定多肽泛素化位点的方法,并用于评价多肽群体中的泛素化靶标。 以这种方式,可以获得包含与多个细胞多肽的泛素化状态有关的信息的蛋白质组泛素化图。 可以获得各种不同类型的细胞和细胞状态的图。 例如,可以评估正常和患病细胞中的泛素化靶标。 优选地,地图作为数据文件存储在数据库中。 鉴定的单个泛素化多肽可用于产生诊断细胞状态的分子探针和/或可用作调节一种或多种细胞过程的试剂的靶标。